[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Lord_of_Biotechs posts on X about $tvrd, $smlr, $asst, $jnj the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXX% finance XXX% cryptocurrencies XXX%
Social topic influence $tvrd #1, $smlr 1.8%, $asst 1.8%, $jnj 0.9%, $ptgx 0.9%, $kzr 0.9%, $vtyx 0.9%, sanofi 0.9%, $rog 0.9%, $bioa XXX%
Top accounts mentioned or mentioned by @investspecial @ltbioinvestor @aaronrosenblum5 @docrodwong @biohazard3737 @richtrades100 @toffcap @monacobiotech @pussenius @lordvultures @steveyonezu @nkt0509 @anotherbio @leosheaux11 @khanosis @biopm1989 @dt432123 @clarkinm @lordofbiotech @olvehe
Top assets mentioned Semler Scientific, Inc. (SMLR) Strive, Inc. (ASST) Johnson & Johnson (JNJ) Protagonist Therapeutics, Inc (PTGX) Sanofi (SNY) ROGin AI (ROG) Apogee Therapeutics, Inc. Common Stock (APGE)
Top posts by engagements in the last XX hours
"$TVRD Cash is 3-4 US$ per share"
X Link @Lord_of_Biotech 2025-10-13T11:40Z 3300 followers, 5985 engagements
"I think $SMLR trades quite fair here as $ASST had their big PIPE at XXXX US$. The effective filing for these shares should be come around the next days according to filing XX days after PIPE closing. PIPE closed at 12th September 2025 so should be around the corner now and the shares can be freely tradeable including the Warrants (1:1 ratio). I think many participants will sell their shares which also implies the option chain which has an fair value around XXXX - XXXX US$. I would not be shocked when $ASST trades between XXXX and XXXX in 2-3 weeks"
X Link @Lord_of_Biotech 2025-10-07T12:15Z 3297 followers, XXX engagements
"$JNJ in Talks to buy $PTGX"
X Link @Lord_of_Biotech 2025-10-10T15:14Z 3296 followers, 14.4K engagements
"$KZR trading XXX% below their projected net cash as of 30th September XX. Will have some newsflow in Q4 XX. I don't care about their science but they look really cheap here based on numbers. They did not get any love here the last weeks. Maybe that will change when they announce something fruitful out of their FDA meeting. best case would be to close down the shop but they already rejected Tang last year. I think the downside shoudl be capped here thats what I like most. Wills till have 850$ net cash per share end of the year"
X Link @Lord_of_Biotech 2025-10-09T16:01Z 3296 followers, 3422 engagements
"$VTYX Have still my shares from the first data run up in spring/summer. Sanofi has first right to negotiate here. Smells like something coming. NLRP3 is en vogue right now. $ROG showed their own NLRP3 some weeks ago. $BIOA also with NLRP3 data end of the year"
X Link @Lord_of_Biotech 2025-10-01T14:55Z 3298 followers, 2651 engagements
"$APGE We can probably say that they want to go alone here"
X Link @Lord_of_Biotech 2025-10-08T20:09Z 3298 followers, 2833 engagements
"And $RTW again - LOL"
X Link @Lord_of_Biotech 2025-10-10T15:55Z 3296 followers, XXX engagements
"$TVRD This thing is done"
X Link @Lord_of_Biotech 2025-10-13T11:38Z 3300 followers, 9978 engagements
"$SMLR already trading as if the merger with $ASST will fail @InvestSpecial"
X Link @Lord_of_Biotech 2025-10-13T15:05Z 3299 followers, 2186 engagements